Ervebo
E414773
Ervebo is a recombinant, live-attenuated vaccine developed to protect humans against infection by the Zaire ebolavirus.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Ervebo canonical | 2 |
How this entity was disambiguated
This entity first appeared as the object of triple T4131898 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Ervebo Context triple: [Ebola virus disease, vaccine, Ervebo]
-
A.
Ehrwald
Ehrwald is a picturesque Austrian village in Tyrol, known as a popular alpine resort and gateway to the Zugspitze massif.
-
B.
Espevær
Espevær is a small island and fishing village in Vestland county, Norway, known for its traditional coastal culture and scenic maritime environment.
-
C.
Buota
Buota is a village located on Tarawa Atoll in the Pacific island nation of Kiribati.
-
D.
Valbo
Valbo is a locality in Gävleborg County, Sweden, known as the hometown of NHL ice hockey star Nicklas Bäckström.
-
E.
Avusy
Avusy is a small rural municipality located in the canton of Geneva in southwestern Switzerland, near the French border.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Ervebo Target entity description: Ervebo is a recombinant, live-attenuated vaccine developed to protect humans against infection by the Zaire ebolavirus.
-
A.
Ehrwald
Ehrwald is a picturesque Austrian village in Tyrol, known as a popular alpine resort and gateway to the Zugspitze massif.
-
B.
Espevær
Espevær is a small island and fishing village in Vestland county, Norway, known for its traditional coastal culture and scenic maritime environment.
-
C.
Buota
Buota is a village located on Tarawa Atoll in the Pacific island nation of Kiribati.
-
D.
Valbo
Valbo is a locality in Gävleborg County, Sweden, known as the hometown of NHL ice hockey star Nicklas Bäckström.
-
E.
Avusy
Avusy is a small rural municipality located in the canton of Geneva in southwestern Switzerland, near the French border.
- F. None of above. chosen
Statements (51)
| Predicate | Object |
|---|---|
| instanceOf |
Ebola vaccine
ⓘ
live-attenuated vaccine ⓘ recombinant vaccine ⓘ vaccine ⓘ |
| hasAdministrationSchedule | single-dose regimen ⓘ |
| hasAdministrationSite | deltoid muscle ⓘ |
| hasATCCode | J07BX02 ⓘ |
| hasClinicalTrialPhase | Phase 3 completed ⓘ |
| hasCommonAdverseEffect |
arthralgia
ⓘ
fatigue ⓘ fever ⓘ headache ⓘ injection site pain ⓘ injection site swelling ⓘ myalgia ⓘ |
| hasComponent |
Zaire ebolavirus glycoprotein
ⓘ
vesicular stomatitis virus glycoprotein G deletion ⓘ |
| hasDeveloper |
Merck & Co.
ⓘ
NewLink Genetics ⓘ Public Health Agency of Canada ⓘ |
| hasDosageForm | suspension for injection ⓘ |
| hasEfficacy | high efficacy against Zaire ebolavirus in clinical trials ⓘ |
| hasGenericName |
rVSV-ZEBOV
ⓘ
rVSV-ZEBOV ⓘ
surface form:
rVSVΔG-ZEBOV-GP
|
| hasIndication |
pre-exposure prophylaxis against Ebola virus disease caused by Zaire ebolavirus
ⓘ
protection of individuals at high risk of exposure to Zaire ebolavirus ⓘ |
| hasMarketingAuthorizationHolder |
Merck & Co.
ⓘ
surface form:
Merck Sharp & Dohme Corp.
|
| hasRegulatoryApproval |
European Commission
ⓘ
Health Canada ⓘ Food and Drug Administration ⓘ
surface form:
U.S. Food and Drug Administration
World Health Organization prequalification ⓘ multiple African national regulatory authorities ⓘ |
| hasRouteOfAdministration | intramuscular injection ⓘ |
| hasStorageRequirement | frozen storage ⓘ |
| hasStorageTemperature | -60°C to -80°C (original formulation) ⓘ |
| hasViralVector | recombinant vesicular stomatitis virus ⓘ |
| hasWHOClassification | Ebola Zaire vaccine ⓘ |
| isAttenuated | true ⓘ |
| isIndicatedForAgeGroup | 18 years and older ⓘ |
| isLive | true ⓘ |
| isRecombinant | true ⓘ |
| isReplicationCompetent | true ⓘ |
| isUsedInOutbreakResponse | true ⓘ |
| targetsDisease | Ebola virus disease ⓘ |
| targetsVirus | Zaire ebolavirus NERFINISHED ⓘ |
| wasApprovedInEUOn | 2019-11-11 ⓘ |
| wasApprovedInUSOn | 2019-12-19 ⓘ |
| wasInitiallyDevelopedBy | Public Health Agency of Canada ⓘ |
| wasPrequalifiedByWHOIn | 2019 ⓘ |
| wasUsedInOutbreak |
2014–2016 West Africa Ebola outbreak
ⓘ
2018–2020 Ebola outbreak in the Democratic Republic of the Congo ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Ervebo Description of subject: Ervebo is a recombinant, live-attenuated vaccine developed to protect humans against infection by the Zaire ebolavirus.
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.